Education
Clifford E. Graham Career Development Award and Developmental Research Program
A generous donation to The University of Texas MD Anderson Cancer Center Institute for Personalized Cancer Therapy permitted us the IPCT to launch a program to train the next generation of translational and clinical researchers in personalized cancer therapy and to support established investigators in the development of new personalized approaches in their research programs through the creation of a Career Development Award (CDA) and Developmental Research Program (DRP). Proposals are accepted annually in the spring.
In year 1 of this program, two Career Development and one Developmental Research Project proposals were funded:
Career Development Awards
Scott Woodman, MD, PhD, Instructor, Department of Melanoma Medical Oncology
“A Genetic and Proteomic Analysis of Acral Lentiginous and Mucosal Melanoma Tumors Before versus During Dasatinib Treatment”
Mentor: Patrick Hwu, MD, Chair and Professor of Melanoma Medical Oncology
Sheeba Thomas, MD, Assistant Professor, Department of Lymphoma/Myeloma
“Chemokine-Idiotype DNA Fusion Vaccines as a Therapeutic Anti-Tumor Strategy for Lymphoplasmocytic Lymphoma”
Mentor: Larry Kwak, MD, PhD, Chair and Professor of Lymphoma/Myeloma
Developmental Research Project Awards
Ju-Seog Lee, PhD, Assistant Professor, Department of Systems Biology
“Validation of Paclitaxel Sensitivity Associated with Silence of Hippo Pathway in Ovarian Cancer”
Khalifa Fellowship Program
The Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy has established a fellowship and investigator program to enhance the education, training and development of physician scientists to excel in the field of personalized cancer therapy and use of molecular and genomic insight to enhance the outcomes of care of cancer patients. Our goal is to identify individuals who demonstrate interest in the development and implementation of personalized cancer therapy aligned with the mission of the Khalifa Institute for Personalized Cancer Therapy and enhance their ability to become leaders in the field of personalized cancer therapy. Visiting Scientists are also welcome to apply. Please check back soon for details.